Brochure | June 28, 2022

SPECTRA OPTIA® Apheresis System

Source: Terumo BCT

Using a patented optical detection system, the AIM system continuously manages the separated layers, allowing the platelet and white blood cell layer to accumulate. AIM then directs the system to efficiently remove the targeted components.

  • Automates interface adjustments without sacrificing your control
  • Monitors and interprets the interface continuously so you don’t have to rely solely on your vision
  • Helps you efficiently remove targeted components
  • Achieves highly predictable results through interface stability
access the Brochure!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

Terumo BCT